| Field | Specification |
|---|---|
| Alternative names | LV-CAG-mCherry | LV-CBA-mCherry | CAG-mCherry Lentivirus |
| Applications | |
| Purity | |
| Titer | |
| Promoter | |
| Reporter/Tag | |
| Expression regulation | |
| Selection marker | None |
| Biosafety level | |
| Storage buffer | |
| Catalog no. (Mfr.) | |
| Main SKU |
Vector Overview
LV-CAG-mCherry is a pre-packaged recombinant lentiviral vector that drives robust expression of the red fluorescent protein mCherry under the control of the CAG promoter (also known as the CBA promoter), a hybrid promoter composed of the CMV immediate early enhancer, the chicken β-actin promoter, and a rabbit β-globin splice acceptor. This promoter is widely used for its strong, ubiquitous expression across a broad range of mammalian cell types, including primary cells and stem cells. The mCherry reporter provides bright, stable red fluorescence, enabling efficient visualization, tracking, and quantification of transduced cells in both in vitro and in vivo experiments. LV-CAG-mCherry is suitable for applications such as monitoring transduction efficiency, cell lineage tracing, and fluorescent labeling of cell populations. The virus is supplied in a ready-to-use format, allowing researchers to bypass vector construction and viral packaging steps and proceed directly to experimental applications.
Technical Details
| Catalog No. | SL100274 |
|---|---|
| Promoter | CAG |
| Reporter / Tag | mCherry |
| Expression Regulation | Constitutive |
| Selection Marker | None |
| Titer | >1E+9 TU/mL |
| Storage Buffer | PBS |
| Purity / Grade | In vivo grade and OK for both in vitro tissue culture infection and in vivo injection * Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm |
| Biosafety Level | BSL-2 |
| Sizes | 25 uL; 25 uL x 2 |
Applications
- Lentiviral Transduction: stable delivery of the cassette into dividing and non-dividing cells for long-term expression.
Biosafety
LV-CAG-mCherry is a pre-packaged lentiviral vector classified as BSL-2. Handle in a certified biosafety cabinet under institutional BSL-2 practices, decontaminate all contact surfaces and waste, and follow local regulations for viral vector work.
Safety & Handling
Store at -80°C; avoid repeated freeze-thaw cycles. Ships on dry ice. Supplied in PBS. For research use only; not for diagnostic or therapeutic use.
Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.
Common customization requests
- Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
- Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
- Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
- Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
- Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).
Add-ons you can request
- Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
- Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
- Documentation: construct map/sequence confirmation package (as available) and batch documentation.
What to include in your request
- Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
- Insert sequence (FASTA) or reference ID, plus any required tags/mutations
- Promoter, reporter, and selection marker preferences
- Desired scale and preferred format (aliquots / concentration requests)
Email us at support@biohippo.com or use the Talk to a Scientist request form.
Li B, Kwon C (2025) Mesendodermal cells fail to contribute to heart formation following blastocyst injection. Biochem Biophys Rep, 43, 102120. 10.1016/j.bbrep.2025.102120
Li B, Kwon C (2024) Mesendodermal cells fail to contribute to heart formation following blastocyst injection. bioRxiv. 10.1101/2024.05.22.595392